High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study

BACKGROUND: Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts. Ursodeoxycholic acid (UDCA) is the only FDA approved first-line therapy for PBC, but up to 40% of patients with PBC have an incomplete response to UDCA....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Huiling, Zheng, Mengyao, He, Haiyu, Lei, Hongtao, Tai, Wenlin, Yang, Jinhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657125/
https://www.ncbi.nlm.nih.gov/pubmed/37978445
http://dx.doi.org/10.1186/s12876-023-03031-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657125/
https://www.ncbi.nlm.nih.gov/pubmed/37978445
http://dx.doi.org/10.1186/s12876-023-03031-8

Ejemplares similares